Chatbot for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new chatbot designed to help people quit smoking. The researchers aim to determine if users like the chatbot and if it aids in smoking cessation. Some participants will use the chatbot, while others will not, to compare results. This trial suits Black or African American individuals living in Minnesota who smoke regularly, want to quit soon, and have a smartphone. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could help many people quit smoking.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you use medicinal nicotine or have a medical condition or medication that could interfere with the study, it might be a concern. It's best to discuss your specific situation with the study team.
What prior data suggests that this chatbot is safe for smoking cessation?
Research shows that chatbots are generally safe and helpful for people trying to quit smoking. Studies have found that these digital tools effectively encourage smoking cessation without causing harm. For example, one study found that chatbots used for quitting smoking successfully engaged users and improved their quitting experience. Another review highlighted the growing importance of chatbots and digital assistants in helping people quit tobacco.
Overall, chatbots don't involve medications or physical treatments, so the risk of side effects remains low. Participants typically interact with the chatbot by typing or speaking, making it a non-invasive option. Users have provided positive feedback, indicating comfort and safety in using these tools.12345Why are researchers excited about this trial?
Researchers are excited about using a chatbot for smoking cessation because it offers a highly personalized and accessible approach to managing smoking triggers. Unlike traditional methods like nicotine replacement therapy or prescription medications, this chatbot provides real-time support and guidance right from your smartphone. Its ability to interact and adapt to individual user needs makes it stand out as a potentially powerful tool in helping people quit smoking.
What evidence suggests that this chatbot is effective for smoking cessation?
Research has shown that chatbots can help people trying to quit smoking. Some studies indicate that digital methods, like text messages, can increase quitting rates by 63%. In this trial, participants in the experimental arm will use a chatbot for managing smoking triggers. Chatbots, especially when combined with motivational techniques, have shown potential in encouraging smoking cessation. As more people turn to apps for quitting, trust in digital tools for this purpose appears to be growing. These findings suggest that chatbots might effectively support and motivate individuals to quit smoking.24678
Are You a Good Fit for This Trial?
This trial is for native English-speaking Black or African American individuals, at least 21 years old, living in Minnesota who smoke regularly and are willing to try quitting within the next month. Participants must have a smartphone capable of running the study app and be able to upload data from it.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are provided with a chatbot to assist with smoking cessation, or are part of a control group
Follow-up
Participants are monitored for the effectiveness of the chatbot and their motivation to quit smoking
What Are the Treatments Tested in This Trial?
Interventions
- Chatbot
Trial Overview
The PASCAL Feasibility Study is testing whether a chatbot can help people quit smoking. It randomly assigns participants into two groups: one will use the chatbot along with their quit attempt, while the other group will not receive any chatbot assistance.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Citations
ChatGPT-Based Chatbot for Help Quitting Smoking via ...
Large language model chatbots such as ChatGPT may be able to provide support to people who smoke cigarettes and are trying to quit.
Efficacy of digital interventions for smoking cessation by ...
SMS interventions demonstrated the highest efficacy (RR 1.63, 95% CI 1.38–1.92), indicating a 63% increased smoking cessation success compared ...
Mixed Methods Study Comparing Motivational Interviewing ...
The results confirmed that chatbots are a promising tool in motivating smoking cessation and the use of MI can improve user experience.
Effectiveness of a Chat Bot for Smoking Cessation ...
This study aims to evaluate the effectiveness of an intervention to help people to quit smoking throughout an chat bot compared with usual assistance to ...
The Contribution of Digital Treatment to Efforts to Reduce ...
The number of people using tobacco-cessation apps worldwide was projected to increase from 5 million in 2022 to 33 million in 2026, in part ...
Outcomes of a Comprehensive Mobile Smoking Cessation ...
This study aimed to compare engagement, retention, attitudes toward quitting smoking, smoking behavior, and participant feedback between Pivot and QuitGuide.
Overview of the emerging role of chatbots, including large ...
Conversational chatbot for cigarette smoking cessation: results from the 11-step user-centered design development process and randomized controlled trial.
The role of chatbots and virtual assistants in enhancing ...
This paper is intended to review the state and success of chatbots and virtual assistants in the delivery of tobacco cessation counselling services.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.